QT
CGON icon

Quantbot Technologies’s CG Oncology CGON Stock Holding History

Quantbot Technologies’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$195K Buy
+2,883
New +$163K 0.01% 1180
2025
Q1 		– Sell
-7
Closed -$201 – 1515
2024
Q4 		$201 Buy
+7
New +$239 ﹤0.01% 1418

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Quantbot Technologies's CGON Position: Q1 2026 in Review

Quantbot Technologies opened a new position in CG Oncology (CGON) in Q1 2026: 2,883 shares worth $195K. The stake represents 0.01% of the portfolio and ranks #1180 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in CGON as recently as Q4 2024.

Quantbot Technologies first reported a position in CGON in Q4 2024 and has held it in 2 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Quantbot Technologies held 2,883 shares of CG Oncology worth $195K as of Q1 2026.
  • CG Oncology was a new Quantbot Technologies position in Q1 2026.
  • CG Oncology made up 0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1180 holding.
  • Quantbot Technologies first reported a position in CG Oncology in Q4 2024 and has held it in 2 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.